Description overdue on 09/15/2014
- Latin name: Broncho-Vaxom
- ATC code: L03A
- Active substance: Lyophilisate bacterial lysates (Moraxella catarrhalis, Klebsiella ozaenae, Klebsiella pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, Haemophilus influenzae, Streptococcus viridans, Streptococcus pneumoniae)
- Manufacturer: OM PHARMA (Switzerland)
- Composition
- Product form
- Pharmacological action
- Pharmacodynamics and pharmacokinetics
- Indications
- Contraindications
- Side effects
- Instructions for use (method and dosage)
- Overdose
- Cooperation
- Terms of sale
- Storage conditions
- Shelf life
- Reviews
- Price, where to buy
Composition
The capsules Broncho-Vaks (Broncho-Vaxom) contain lyophilizate bacterial lysates ( Moraxella catanhalis . Haemophilus influenzae . Staphylococcus aureus . Klebsiella pneumoniae . Streptococcus viridans . Klebsiella ozaenae . Streptococcus pneumoniae . Streptococcus pyogenes ).
In addition, they contain the following additional components: propyl, mannitol, magnesium stearate, indigotine, gelatin, anhydrous sodium glutamate, pregelatinized starch, titanium dioxide.
Product form
The drug is sold in capsules, which are contoured in containers (each containing 10 pcs.). They are kept in cardboard packets. In each of them one or 3-outline package.
Pharmacological action
The drug is an immunostimulatory agent.
Pharmacodynamics and pharmacokinetics
The drug has immunostimulating action. It promotes education immunoglobulins A, G, M Secreting airway mucosa. Furthermore, increases the number of T-lymphocyte .
When using the drug reduced the risk of infection during epidemics of respiratory tract infections, in addition, reduces the severity of the disease and the time of its stretch. Also significantly reduces the risk of bacterial complications acute respiratory infections .
Indications
For adults and children the drug is used for the following indicators:
- the need to prevent re-infection of the respiratory tract;
- the need to prevent deterioration bronchitis ;
- acute respiratory tract infections .
Contraindications
The drug is contraindicated in:
- children aged up to six months;
- breast-feeding ;
- first trimester pregnancy ;
- hypersensitivity to its components.
Side effects
Unwanted side effects when using the drug observed very rarely, however, in rare cases possible nausea . cough . headache . dyspeptic symptoms . breathlessness .
In addition, there may be excessive fatigue and allergy . It was also reported cases of idiopathic urticaria . purpura . tachycardia . thrombocytopenia . arthralgia . But their connection with the course of Broncho-Vaksoma still not proven.
When side effects you should immediately contact the person who must decide whether to continue treatment.
Instructions for use (method and dosage)
Adult and children Broncho-Vaks administered orally.
Adults and children over 12 years old need to take one capsule funds Broncho-adult Vaks every day before eating in the morning, until the symptoms disappear. The course lasts for at least 10 days. If you need another treatment, its duration should be determined by a specialist, based on the patient's condition.
When relapse prevention and maintenance therapy of daily administration of the scheme is the same. The course lasts for three cycles (each of them - 10 days), the interval between - 20 days.
The capsules can be opened and their contents mixed with water, fruit juice, milk and other beverages.
For children from 6 months to 12 years, experts appointed Broncho-Vaks children . This drug should also take capsule daily in the morning before eating. It is recommended to calculate the course of 10 days. The contents of the capsule may be dissolved in water, juice, tea.
If necessary, the treatment can be repeated. Thus, for maximum effect, some patients are prescribed three course at intervals of 20 days in between.
Overdose
Information about the missing cases of overdose.
Cooperation
The interaction of the agent with other drugs has not been studied.
Terms of sale
The drug is sold by prescription.
Storage conditions
The optimum temperature - 15-25 ° C. The capsules should be kept in their original packaging.
Shelf life
The medicine should be stored no longer than 5 years.
Reviews
Broncho-Vaks received mostly positive reviews. Patients say that it helps to transfer disease in a milder form, and to avoid further complications. Many, however, requires not one but several courses of therapy. On the side-effects of the reviews are not reported.
Price Broncho-Vaksoma where to buy
Price Broncho-adult Vaks 10 packs in a carton box, an average of 400 rubles. Slightly lower cost medication to a child - about 360 rubles. Cost Broncho-Vaks children in Ukraine - about 117 hryvnia, and adult drug - 133 hryvnia.
No comments:
Post a Comment